期刊文献+

Activation Effect of Cathartic Natural Compound Rhein to CFTR Chloride Channel

Activation Effect of Cathartic Natural Compound Rhein to CFTR Chloride Channel
暂未订购
导出
摘要 The cystic fibrosis transmembrane conductance regulator (CFFR) is a cAMP-activated chloride channel expressed in intestinal exoerine glands, which plays a key role in intestinal fluid secretion. A natural anthraquinone ac tivator of CFTR Cl^- channel, rhein, was identified by screening 217 single compounds from Chinese herbs via a cellbased halide-sensitive fluorescent assay. Rhein activates CFTR Cl^- transportation in a dose-dependent manner in the presence of cAMP with a physiological concentration. This study provides a novel molecular pharmacological mechanism for the laxative drugs in Treditional Chinese Medicine such as aloe, cascara and senna. The cystic fibrosis transmembrane conductance regulator (CFFR) is a cAMP-activated chloride channel expressed in intestinal exoerine glands, which plays a key role in intestinal fluid secretion. A natural anthraquinone ac tivator of CFTR Cl^- channel, rhein, was identified by screening 217 single compounds from Chinese herbs via a cellbased halide-sensitive fluorescent assay. Rhein activates CFTR Cl^- transportation in a dose-dependent manner in the presence of cAMP with a physiological concentration. This study provides a novel molecular pharmacological mechanism for the laxative drugs in Treditional Chinese Medicine such as aloe, cascara and senna.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2006年第3期312-314,共3页 高等学校化学研究(英文版)
基金 SupportedbytheNationalNaturalScienceFundforDistinguishedYoungScholars(No.30325011),theNationalNaturalScienceFoundationofChina(Nos.30470405and30570864),DistinguishedYoungScholarsFundofJilinProvince(No.20030112),andExcellentYoungTeachersProgramofMOE,China.
关键词 CFTR chloride channel ANTHRAQUINONE Laxative drug CFTR chloride channel Anthraquinone Laxative drug
  • 相关文献

参考文献14

  • 1Yagi T. , Yamauchi K. , J. Pharm. Pharmacol. , 1999, 51 ( 1 ),93
  • 2Al-Awqati Q. , J. Clin. Invest. , 2002, 110( 11 ), 1599
  • 3Ma T. , Thiagarajah J. R. , Yang H. , et al. , J. Clin. Invest. ,2002, 110(11), 1651
  • 4Wanitschke R. , Karbach V. , Pharmacology, 1988,36( Suppl. 1 ), 98
  • 5Anderson M. P. , Goldhill J. , Berger H. A. , et al. , Am.J.Physiol. , 1992, 263 : L1
  • 6Cheng Y. W. , Kang J. J. Br. , J. Pharmacol. , 1998: 123,815
  • 7Beubler E. , Kollar G. , Pharmacology, 1988 : 36 ( Suppl. 1 ), 85
  • 8Capasso F. , Mascolo N. , Autore G. , et al. , J. Pharm. Pharmacol. , 1986, .38,627
  • 9Beubler E., Schirgi-Degen A., Pharmacology, 1993: 47(Suppl. 1), 64
  • 10Izzo A. A. , Gaginella T. S. , Mascolo N. , et al. , Ear. J.Pharmacol., 1996, 301, 137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部